Skip to main content

Johnson & Johnson cash flow statement

  • JNJ · NYSE
  • Healthcare
  • Pharmaceuticals
  • S&P 500
$285.75+0.79%Close 13 Nov 2026 · Market value $684.4B

In fiscal 2025 (the year to 28 Dec 2025), Johnson & Johnson generated $24.53B of operating cash flow and $19.70B of free cash flow, after $4.83B of capital expenditure.

From Johnson & Johnson's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 28 Dec 2025. TTM is the last four reported quarters added up.

Annual

Johnson & Johnson cash flow statement, annual
USDFY 2007FY 2008FY 2009FY 2010FY 2011FY 2012FY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Net income$10.58B$12.95B$12.27B$13.33B$9.67B$10.85B$13.83B$16.32B$15.41B$16.54B$1.30B$15.30B$15.12B$14.71B$20.88B$17.94B$35.15B$14.07B$26.80B$16.09B
Depreciation & amortization$2.78B$2.83B$2.77B$2.94B$3.16B$3.67B$4.10B$3.90B$3.75B$3.75B$5.64B$6.93B$7.01B$7.23B$7.39B$6.97B$7.49B$7.34B$7.50B$8.09B
Stock-based compensation$698.0M$627.0M$628.0M$614.0M$621.0M$662.0M$728.0M$792.0M$874.0M$878.0M$962.0M$978.0M$977.0M$1.00B$1.14B$1.14B$1.16B$1.18B$1.35B$1.42B
Operating cash flow$15.02B$14.97B$16.57B$16.39B$14.30B$15.40B$17.41B$18.71B$19.57B$18.77B$21.06B$22.20B$23.42B$23.54B$23.41B$21.19B$22.79B$24.27B$24.53B$26.16B
Operating cash flow margin24.6%23.5%26.8%26.6%22.0%22.9%24.4%25.2%27.9%26.1%27.5%27.2%28.5%28.5%29.7%26.5%26.8%27.3%26.0%26.3%
Capital expenditures$2.94B$3.07B$2.37B$2.38B$2.89B$2.93B$3.60B$3.71B$3.46B$3.23B$3.28B$3.67B$3.50B$3.35B$3.65B$4.01B$4.54B$4.42B$4.83B$5.57B
Acquisitions$1.39B$1.21B$2.47B$1.27B$2.80B$4.49B$835.0M$2.13B$954.0M$4.51B$35.15B$899.0M$5.81B$7.32B$60.00M$17.65B$0.00$15.15B$17.54B$37.73B
Free cash flow$12.08B$11.91B$14.21B$14.00B$11.40B$12.46B$13.82B$15.00B$16.11B$15.54B$17.78B$18.53B$19.92B$20.19B$19.76B$17.18B$18.25B$19.84B$19.70B$20.59B
Free cash flow margin19.8%18.7%23.0%22.7%17.5%18.5%19.4%20.2%23.0%21.6%23.3%22.7%24.3%24.4%25.1%21.5%21.4%22.3%20.9%20.7%
Free cash flow per share$4.15$4.20$5.09$5.02$4.11$4.43$4.80$5.24$5.73$5.57$6.48$6.79$7.42$7.56$7.39$6.45$7.13$8.17$8.11$8.42
Dividends paid$4.67B$5.02B$5.33B$5.80B$6.16B$6.61B$7.29B$7.77B$8.17B$8.62B$8.94B$9.49B$9.92B$10.48B$11.03B$11.68B$11.77B$11.82B$12.38B$12.72B
Gross share repurchases$5.61B$6.65B$2.13B$2.80B$2.52B$12.92B$3.54B$7.12B$5.29B$8.98B$6.36B$5.87B$6.75B$3.22B$3.46B$6.04B$5.05B$2.43B$5.95B$7.88B
Stock issuance proceeds$1.56B$1.49B$882.0M$1.23B$1.25B———————————————
Net share repurchases$4.04B$5.17B$1.25B$1.57B$1.28B$12.92B$3.54B$7.12B$5.29B$8.98B$6.36B$5.87B$6.75B$3.22B$3.46B$6.04B$5.05B$2.43B$5.95B$7.88B
Cash interest paid$314.0M$525.0M$533.0M$491.0M$492.0M$501.0M$491.0M$488.0M$515.0M$628.0M$866.0M$963.0M$925.0M$841.0M$941.0M$933.0M$1.77B$1.91B$1.86B—
Free cash flow after SBC$11.38B$11.28B$13.58B$13.39B$10.78B$11.80B$13.09B$14.20B$15.23B$14.66B$16.82B$17.55B$18.94B$19.18B$18.62B$16.05B$17.09B$18.67B$18.34B$19.17B

Quarterly

Johnson & Johnson cash flow statement, quarterly
USDQ4 FY2023Q1 FY2024Q2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026
Net income$4.05B$3.25B$4.69B$2.69B$3.43B$11.00B$5.54B$5.15B$5.12B$5.24B$5.53B$210.0M
Depreciation & amortization$1.84B$1.81B$1.78B$1.85B$1.90B$1.77B$1.94B$1.78B$2.01B$2.00B$1.96B$2.12B
Stock-based compensation$178.0M$302.0M$341.0M$295.0M$238.0M$288.0M$410.0M$347.0M$309.0M$300.0M$458.0M$357.0M
Operating cash flow$7.86B$3.66B$5.63B$7.99B$6.98B$4.17B$3.88B$9.17B$7.31B$2.51B$8.62B$7.72B
Operating cash flow margin36.8%17.1%25.1%35.6%31.0%19.1%16.3%38.2%29.8%10.4%34.0%30.4%
Capital expenditures$1.59B$807.0M$976.0M$1.03B$1.61B$795.0M$1.04B$1.16B$1.84B$1.05B$1.32B$1.36B
Acquisitions$0.00$1.81B$13.00B$338.0M$1.00M$0.00$14.46B$1.00M$3.08B$17.50B$0.00$17.15B
Free cash flow$6.27B$2.85B$4.66B$6.96B$5.37B$3.38B$2.83B$8.01B$5.47B$1.47B$7.29B$6.36B
Free cash flow margin29.3%13.3%20.7%31.0%23.8%15.4%11.9%33.4%22.3%6.1%28.8%25.0%
Free cash flow per share$2.58$1.17$1.92$2.87$2.21$1.39$1.17$3.30$2.24$0.60$2.99$2.60
Dividends paid$2.87B$2.87B$2.98B$2.98B$2.98B$2.99B$3.13B$3.13B$3.13B$3.13B$3.23B$3.23B
Gross share repurchases$216.0M$1.48B$136.0M$539.0M$282.0M$2.13B$0.00$1.90B$1.92B$4.03B$221.0M$1.71B
Net share repurchases$216.0M$1.48B$136.0M$539.0M$282.0M$2.13B$0.00$1.90B$1.92B$4.03B$221.0M$1.71B
Free cash flow after SBC$6.10B$2.55B$4.32B$6.67B$5.13B$3.09B$2.42B$7.67B$5.16B$1.17B$6.84B$6.00B

The main figures as JSON and plain text. See data and methodology.

JNJ in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.